BODY MASS INDEX IN MULTIPLE SCLEROSIS: ASSOCIATION WITH SERUM LEPTIN

Abstract

ultiple sclerosis (MS) is an inflammatory demyelinating and neurodegenerative disease affecting more than 2 million people worldwide (Heydarpour et al., 2015). Multiple sclerosis is a relatively common disease in Europe, the United States, Canada, New Zealand, and parts of Australia. Incidence is low in childhood, increases rapidly after the age of 18, reaches a peak between 25 and 35 years (about 2 years earlier in women than men), and then slowly declines, becoming rare at age 50 and older. The female-to-male ratios are between 1.5 and 2.5 in most populations (Ascherio and Munger, 2007).